PDF herunterladen
Semin Thromb Hemost 2017; 43(05): 525-529
DOI: 10.1055/s-0037-1599143
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Role of ABO Blood Type in Thrombosis Scoring Systems

Massimo Franchini
1   Department of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy
2   Italian National Blood Centre, National Institute of Health, Rome, Italy
,
Giuseppe Marano
2   Italian National Blood Centre, National Institute of Health, Rome, Italy
,
Stefania Vaglio
2   Italian National Blood Centre, National Institute of Health, Rome, Italy
3   Department of Clinical and Molecular Medicine, “Sapienza” University of Rome, Rome, Italy
,
Liviana Catalano
2   Italian National Blood Centre, National Institute of Health, Rome, Italy
,
Simonetta Pupella
2   Italian National Blood Centre, National Institute of Health, Rome, Italy
,
Giancarlo Maria Liumbruno
2   Italian National Blood Centre, National Institute of Health, Rome, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
15. März 2017 (online)

    Lizenzen und Reprints

Abstract

In addition to their major role in transfusion medicine, there is increasing evidence that ABO blood group antigens (complex carbohydrate molecules widely expressed on the surface of red blood cells and several other cell types) are implicated in the development of a wide array of pathologic conditions. In particular, intense research has been dedicated over the last 50 years to the study of the association between non-O blood type and the risk of developing cardiovascular disorders. Several pathways have been hypothesized to explain this relationship, the most reasonable implying the influence of the ABO blood group on circulating plasma levels of von Willebrand factor, factor VIII, and several inflammatory cytokines. This narrative review summarizes the current knowledge on the role of ABO antigens in both venous and arterial thromboses, focusing on their association with clinical scoring systems evaluating thrombotic risk.

Keywords

ABO blood group - arterial thrombosis - venous thromboembolism - scoring systems
 

  • References

  • 1 Storry JR, Olsson ML. The ABO blood group system revisited: a review and update. Immunohematology 2009; 25 (02) 48-59
    CrossrefPubMedGoogle Scholar
  • 2 Yamamoto F, Cid E, Yamamoto M, Blancher A. ABO research in the modern era of genomics. Transfus Med Rev 2012; 26 (02) 103-118
    CrossrefPubMedGoogle Scholar
  • 3 Lowe JB. The blood group-specific human glycosyltransferases. Baillieres Clin Haematol 1993; 6 (02) 465-492
    CrossrefPubMedGoogle Scholar
  • 4 Eastlund T. The histo-blood group ABO system and tissue transplantation. Transfusion 1998; 38 (10) 975-988
    CrossrefPubMedGoogle Scholar
  • 5 Anstee DJ. The relationship between blood groups and disease. Blood 2010; 115 (23) 4635-4643
    CrossrefPubMedGoogle Scholar
  • 6 Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 2012; 49 (04) 137-149
    CrossrefPubMedGoogle Scholar
  • 7 Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus 2013; 11 (04) 491-499
    PubMedGoogle Scholar
  • 8 Franchini M, Mannucci PM. ABO blood group and thrombotic vascular disease. Thromb Haemost 2014; 112 (06) 1103-1109
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 9 Franchini M, Lippi G. Relative risks of thrombosis and bleeding in different ABO blood groups. Semin Thromb Hemost 2016; 42 (02) 112-117
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 10 Franchini M, Liumbruno GM. ABO blood group and neurodegenerative disorders: more than a casual association. Blood Transfus 2016; 14 (02) 158-159
    Google Scholar
  • 11 Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood Transfus 2016; 14 (05) 434-440
    PubMedGoogle Scholar
  • 12 Liumbruno GM, Franchini M. Hemostasis, cancer, and ABO blood group: the most recent evidence of association. J Thromb Thrombolysis 2014; 38 (02) 160-166
    CrossrefPubMedGoogle Scholar
  • 13 Franchini M, Liumbruno GM. ABO blood group: old dogma, new perspectives. Clin Chem Lab Med 2013; 51 (08) 1545-1553
    PubMedGoogle Scholar
  • 14 Dick W, Schneider W, Brockmueller K, Mayer W. Interrelations of thromboembolic diseases and blood group distribution. Thromb Diath Haemorrh 1963; 143: 472-474
    PubMedGoogle Scholar
  • 15 Medalie JH, Levene C, Papier C. , et al. Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med 1971; 285 (24) 1348-1353
    CrossrefPubMedGoogle Scholar
  • 16 Whincup PH, Cook DG, Phillips AN, Shaper AG. ABO blood group and ischaemic heart disease in British men. BMJ 1990; 300 (6741): 1679-1682
    CrossrefPubMedGoogle Scholar
  • 17 Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345 (8943): 152-155
    CrossrefPubMedGoogle Scholar
  • 18 Carpeggiani C, Coceani M, Landi P, Michelassi C, L'abbate A. ABO blood group alleles: A risk factor for coronary artery disease. An angiographic study. Atherosclerosis 2010; 211 (02) 461-466
    CrossrefPubMedGoogle Scholar
  • 19 Wolpin BM, Kabrhel C, Varraso R. , et al. Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies. Thromb Haemost 2010; 104 (05) 962-971
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 20 Spiezia L, Campello E, Bon M. , et al. ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia. Blood Transfus 2013; 11 (02) 250-253
    PubMedGoogle Scholar
  • 21 Etemadi A, Kamangar F, Islami F. , et al. Mortality and cancer in relation to ABO blood group phenotypes in the Golestan cohort study. BMC Med 2015; 13: 8
    CrossrefPubMedGoogle Scholar
  • 22 Vasan SK, Rostgaard K, Majeed A. , et al. ABO blood group and risk of thromboembolic and arterial disease: a study of 1.5 million blood donors. Circulation 2016; 133 (15) 1449-1457 , discussion 1457
    CrossrefPubMedGoogle Scholar
  • 23 Reilly MP, Li M, He J. , et al; Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011; 377 (9763): 383-392
    CrossrefPubMedGoogle Scholar
  • 24 Williams FM, Carter AM, Hysi PG. , et al; EuroCLOT Investigators; Wellcome Trust Case Control Consortium 2; MOnica Risk, Genetics, Archiving and Monograph; MetaStroke; International Stroke Genetics Consortium. Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol 2013; 73 (01) 16-31
    Google Scholar
  • 25 Trégouët DA, Heath S, Saut N. , et al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009; 113 (21) 5298-5303
    CrossrefPubMedGoogle Scholar
  • 26 Dichgans M, Malik R, König IR. , et al; METASTROKE Consortium; CARDIoGRAM Consortium; C4D Consortium; International Stroke Genetics Consortium. Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke 2014; 45 (01) 24-36
    CrossrefPubMedGoogle Scholar
  • 27 Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6 (01) 62-69
    PubMedGoogle Scholar
  • 28 He M, Wolpin B, Rexrode K. , et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012; 32 (09) 2314-2320
    CrossrefPubMedGoogle Scholar
  • 29 Dentali F, Sironi AP, Ageno W. , et al. Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 2012; 38 (05) 535-548
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 30 Dentali F, Sironi AP, Ageno W, Crestani S, Franchini M. ABO blood group and vascular disease: an update. Semin Thromb Hemost 2014; 40 (01) 49-59
    PubMedGoogle Scholar
  • 31 Takagi H, Umemoto T. ; All-Literature Investigation of Cardiovascular Evidence (ALICE) Group. Meta-analysis of non-O blood group as an independent risk factor for coronary artery disease. Am J Cardiol 2015; 116 (05) 699-704
    CrossrefPubMedGoogle Scholar
  • 32 Chen Z, Yang SH, Xu H, Li JJ. ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis. Sci Rep 2016; 6: 23250
    CrossrefPubMedGoogle Scholar
  • 33 Schunkert H, König IR, Kathiresan S. , et al; Cardiogenics; CARDIoGRAM Consortium. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 43 (04) 333-338
    CrossrefPubMedGoogle Scholar
  • 34 Jenkins PV, O'Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?. Transfusion 2006; 46 (10) 1836-1844
    CrossrefPubMedGoogle Scholar
  • 35 Campos M, Sun W, Yu F. , et al. Genetic determinants of plasma von Willebrand factor antigen levels: a target gene SNP and haplotype analysis of ARIC cohort. Blood 2011; 117 (19) 5224-5230
    CrossrefPubMedGoogle Scholar
  • 36 Campos M, Buchanan A, Yu F. , et al. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC study. Blood 2012; 119 (08) 1929-1934
    CrossrefPubMedGoogle Scholar
  • 37 Casari C, Lenting PJ, Wohner N, Christophe OD, Denis CV. Clearance of von Willebrand factor. J Thromb Haemost 2013; 11 (Suppl. 01) 202-211
    CrossrefPubMedGoogle Scholar
  • 38 Preston RJ, Rawley O, Gleeson EM, O'Donnell JS. Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities. Blood 2013; 121 (19) 3801-3810
    CrossrefPubMedGoogle Scholar
  • 39 Rastegarlari G, Pegon JN, Casari C. , et al. Macrophage LRP1 contributes to the clearance of von Willebrand factor. Blood 2012; 119 (09) 2126-2134
    CrossrefPubMedGoogle Scholar
  • 40 Paré G, Chasman DI, Kellogg M. , et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008; 4 (07) e1000118
    CrossrefPubMedGoogle Scholar
  • 41 Karakas M, Baumert J, Kleber ME. , et al. A variant in the ABO gene explains the variation in soluble E-selectin levels-results from dense genotyping in two independent populations. PLoS One 2012; 7 (12) e51441
    CrossrefPubMedGoogle Scholar
  • 42 Paterson AD, Lopes-Virella MF, Waggott D. , et al; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Genome-wide association identifies the ABO blood group as a major locus associated with serum levels of soluble E-selectin. Arterioscler Thromb Vasc Biol 2009; 29 (11) 1958-1967
    CrossrefPubMedGoogle Scholar
  • 43 Zhong M, Zhang H, Reilly JP. , et al. ABO blood group as a model for platelet glycan modification in arterial thrombosis. Arterioscler Thromb Vasc Biol 2015; 35 (07) 1570-1578
    CrossrefPubMedGoogle Scholar
  • 44 Chasman DI, Paré G, Mora S. , et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet 2009; 5 (11) e1000730
    CrossrefPubMedGoogle Scholar
  • 45 Chen Y, Chen C, Ke X. , et al. Analysis of circulating cholesterol levels as a mediator of an association between ABO blood group and coronary heart disease. Circ Cardiovasc Genet 2014; 7 (01) 43-48
    Google Scholar
  • 46 Franchini M, Mengoli C, Capuzzo E, Terenziani I, Bonfanti C, Lippi G. Correlation between ABO blood group, and conventional hematological and metabolic parameters in blood donors. Semin Thromb Hemost 2016; 42 (01) 75-86
    PubMedGoogle Scholar
  • 47 Robert A, Aillaud MF, Eschwège V, Randrianjohany A, Scarabin Y, Juhan-Vague I. ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden. Thromb Haemost 2000; 83 (04) 630-631
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 48 Morelli VM, De Visser MCH, Vos HL, Bertina RM, Rosendaal FR. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost 2005; 3 (01) 183-185
    CrossrefPubMedGoogle Scholar
  • 49 Ohira T, Cushman M, Tsai MY. , et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 2007; 5 (07) 1455-1461
    CrossrefPubMedGoogle Scholar
  • 50 Miñano A, Ordóñez A, España F. , et al. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms. Haematologica 2008; 93 (05) 729-734
    CrossrefPubMedGoogle Scholar
  • 51 El-Galaly TC, Kristensen SR, Overvad K, Steffensen R, Tjønneland A, Severinsen MT. Interaction between blood type, smoking and factor V Leiden mutation and risk of venous thromboembolism: a Danish case-cohort study. J Thromb Haemost 2012; 10 (10) 2191-2193
    CrossrefPubMedGoogle Scholar
  • 52 Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. CMAJ 2013; 185 (05) E229-E237
    CrossrefPubMedGoogle Scholar
  • 53 Muellner SK, Haut ER, Streiff MB, Holcomb JB, Cotton BA. ABO blood group as a potential risk factor for venous thromboembolism in acutely injured patients. Thromb Haemost 2011; 105 (01) 5-13
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 54 Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 2004; 100 (08) 1717-1723
    CrossrefPubMedGoogle Scholar
  • 55 Larsen TB, Johnsen SP, Gislum M, Møller CAI, Larsen H, Sørensen HT. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost 2005; 3 (02) 300-304
    CrossrefPubMedGoogle Scholar
  • 56 Canonico M, Olié V, Carcaillon L, Tubert-Bitter P, Scarabin PY. ; EStrogen and THromboEmbolism Risk (ESTHER) Study Group. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: the ESTHER study. Thromb Haemost 2008; 99 (01) 246-248
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 57 Guimarães DA, dos Santos MS, Gomes KB. , et al. Interaction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal women. Menopause 2012; 19 (03) 339-345
    CrossrefPubMedGoogle Scholar
  • 58 Yang N, Zhang B, Xie L. , et al. The association baseline NIH Stroke Scale score with ABO blood-subtypes in young patients with acute ischemic stroke. Atherosclerosis 2014; 236 (01) 144-149
    CrossrefPubMedGoogle Scholar
  • 59 Gong P, Luo SH, Li XL. , et al. Relation of ABO blood groups to the severity of coronary atherosclerosis: an Gensini score assessment. Atherosclerosis 2014; 237 (02) 748-753
    CrossrefPubMedGoogle Scholar
  • 60 Capuzzo E, Bonfanti C, Frattini F. , et al. The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program. Ann Transl Med 2016; 4 (10) 189
    CrossrefPubMedGoogle Scholar
  • 61 Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991; 83 (01) 356-362
    CrossrefPubMedGoogle Scholar
  • 62 Huang W, Anderson FA, Spencer FA, Gallus A, Goldberg RJ. Risk-assessment models for predicting venous thromboembolism among hospitalized non-surgical patients: a systematic review. J Thromb Thrombolysis 2013; 35 (01) 67-80
    CrossrefPubMedGoogle Scholar